People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arbor Biotechnologies, Inc. | — | Biotechnology | Series D+ | $230.6M | $5.7B | 2021 |
| Generation Bio Co. | — | Biotechnology | Series D+ | $211.8M | $4.6B | 2018 |
| Canvas Solutions Inc | — | Other Technology | Series A | $22.3M | $166.4M | 2010 |
| Zubie, Inc. | — | Other Technology | Series A | $17.5M | $51.9M | 2013 |
Mark Angelino at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Angelino on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Murphy | 1 | 17 |
| Paul Meister | 1 | 12 |
| Keith Crandell | 1 | 11 |
| Chen Yu | 1 | 7 |
| Kuk Yi | 1 | 7 |
| David Walt | 1 | 6 |
| Paul Asel | 1 | 6 |
| Marc Rubin | 1 | 6 |
| Jeff Jonas | 1 | 5 |
| Nate Lentz | 1 | 5 |
| Lance LeMay | 1 | 5 |
| David R. Walt | 1 | 5 |
| Ted Ridgway | 1 | 4 |
| Mark Walsh | 1 | 4 |
| Kathryn Walker | 1 | 4 |
| Tim Kelly | 1 | 4 |
| David Cheng | 1 | 3 |
| Edward McCarthy | 1 | 3 |
| Jason Rhodes | 1 | 3 |
| Kelly Morgan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.